Curaleaf appoints Torsten Greif to its Board to boost European cannabis market growth.

Curaleaf Holdings has appointed Torsten Greif, co-founder of Four 20 Pharma GmbH, to its Board of Directors. Greif brings expertise in cannabis cultivation, regulatory strategy, and brand development, crucial for expanding Curaleaf's presence in the European medical cannabis market, particularly Germany. This move supports Curaleaf's strategy to scale its European operations and enhance innovation in regulated markets. Greif's leadership is expected to accelerate Curaleaf's growth and contribute to the broader acceptance of cannabis in Europe.